34 results
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Feb 24
Interim condensed consolidated financial statements of
7:30am
shareholders to assert a material influence over the Company’s operations and governance;
the adverse impact of factors outside our control
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
14 Nov 23
Interim condensed consolidated financial statements of
12:00am
and governance;
the adverse impact of factors outside our control, such as global health pandemics, natural disasters, geopolitical conflict and macroeconomic
6-K
EX-99.1
MDNAF
Medicenna Therapeutics Corp.
28 Aug 23
Current report (foreign)
4:49pm
Member of the Audit Committee.
Member of the Compensation Committee.
Member of the Corporate Governance and Nominating Committee.
Lead Director … . Sampson has served on multiple Scientific and Governance Boards in publicly traded biotechnology companies along with major non-profit health delivery
6-K
EX-99.2
MDNAF
Medicenna Therapeutics Corp.
28 Jul 23
Interim condensed consolidated financial statements of
8:31am
shareholders to assert a material influence over the Company’s operations and governance;
the adverse impact of factors outside our control, such as global
6-K
EX-99.2
2yoh99u n1aqr
4 Nov 22
Interim condensed consolidated financial statements of
8:00am
6-K
EX-99.1
nlyyg2bpgmwq7 6ztfya
22 Aug 22
Current report (foreign)
11:39am
6-K
EX-99.2
v9y5i ff8q74fxn8
15 Aug 22
Interim Condensed Consolidated Statements of Financial Position
8:00am
SUPPL
8j7ze1kk
10 Aug 22
Supplemental materials (foreign)
3:10pm
SUPPL
bi60uqyee06d1bf74r6
8 Aug 22
Supplemental materials (foreign)
8:40pm
20-F
EX-15.2
etjfu
22 Jun 22
Annual report (foreign)
5:04pm
20-F
l4s t4dlbkwontyvt
22 Jun 22
Annual report (foreign)
5:04pm
20-F
EX-15.1
16locxb qiddbwp9x7o
22 Jun 22
Annual report (foreign)
5:04pm
6-K
EX-99.1
8gb4k3wny9yu
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.3
nad81yk7o24ad4
22 Jun 22
Current report (foreign)
8:00am
6-K
EX-99.2
lab 0leq6dfh3zha8
9 Feb 22
Interim condensed consolidated financial statements of
7:18am
6-K
EX-99.2
nh3r7h7lkd043myx7e
12 Nov 21
Interim condensed consolidated financial statements of
7:15am
6-K
EX-99.1
8wrj h4r926j6nwrkd
23 Sep 21
Medicenna Appoints Dr. John H. Sampson to its Board of Directors
5:28pm
6-K
EX-99.1
ytraj0gliuxj
1 Sep 21
Current report (foreign)
8:00am